Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RLMD

Relmada Therapeutics Inc

Jun 18 • 04:00PM ET

6.73

+0.13 1.97 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AXSM KYMR RYTM INCY NUVL BMRN NBIX VKTX KRYS MDGL

| Held by: VTI VXF PSIL VHT ITOT SBIO BBC ONEQ AVSC PRFZ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	13.80%	Shs Outstand	104.89M	Perf Week	3.22%
Market Cap	705.91M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.00%	Shs Float	90.42M	Perf Month	-4.27%
Enterprise Value	471.95M	PEG	-	EPS next Q	-0.20	Inst Own	71.10%	Short Float	6.46%	Perf Quarter	7.68%
Income	-58.88M	P/S	-	EPS this Y	42.99%	Inst Trans	31.92%	Short Ratio	4.69	Perf Half Y	49.56%
Sales	0.00M	P/B	3.23	EPS next Y	-16.73%	ROA	-44.77%	Short Interest	5.84M	Perf YTD	39.34%
Book/sh	2.09	P/C	3.02	EPS next 5Y	13.22%	ROE	-48.83%	52W High	8.00 -15.87%	Perf Year	861.57%
Cash/sh	2.23	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-26.92%	52W Low	0.52 1194.23%	Perf 3Y	158.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.83% 6.04%	Perf 5Y	-78.22%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	55.59%	Oper. Margin	-	ATR (14)	0.43	Perf 10Y	-39.04%
Dividend Ex-Date	-	Quick Ratio	18.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.85	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.26	EPS Q/Q	61.90%	SMA20	1.36%	Beta	0.43	Target Price	12.67
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.21%	Rel Volume	3.30	Prev Close	6.60
Employees	17	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	46.03%	Avg Volume	1.25M	Price	6.73
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.84% -	Trades		Volume	4,104,888	Change	1.97%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)